Form 4: Abbott Laboratories Executive Reports Routine Share Disposition for Tax Purposes

An Executive Vice President at Abbott Laboratories reported a routine disposition of common shares to cover tax withholding obligations, while maintaining substantial beneficial ownership.

Summary

• Louis H. Morrone, Executive Vice President of Abbott Laboratories (ABT), reported a disposition of 269 common shares without par value.
• The transaction occurred on June 30, 2025, at a price of $134.38 per share.
• The disposition was coded 'F', indicating it was a payment of tax liability by delivering or withholding securities.
• Following this transaction, Mr. Morrone directly beneficially owns 66,609 common shares.
• Additionally, Mr. Morrone indirectly beneficially owns 12 common shares through the Abbott Laboratories Stock Retirement Trust as of June 30, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine, non-discretionary disposition for tax purposes, which is a standard part of executive compensation and compliance.

Positives

• The reported transaction is a routine disposition of shares for tax withholding purposes, which is a standard practice for executive compensation.
• The Executive Vice President retains a substantial beneficial ownership of 66,609 direct shares and 12 indirect shares, indicating continued alignment with shareholder interests.

Negatives

• A minor reduction in direct share ownership due to the disposition of 269 shares for tax withholding.

Risks

• The disposition represents a slight decrease in direct insider ownership, though it is a routine, non-discretionary transaction for tax purposes and not indicative of a lack of confidence.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction report is specific to an individual executive's share activity and does not provide broader insights into industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Minimal impact as it is a small, routine transaction for tax purposes and the executive retains substantial ownership.

Key Dates

Keywords

Abbott Laboratories, ABT, SEC Form 4, Insider Transaction, Share Disposition, Executive Compensation, Tax Withholding, Beneficial Ownership